Heiko Blaser, University of Toronto

Research

Biologics Cancer Monoclonal Antibodies Oncology Patient Derived Xenograft Pre-Clinical Therapeutics

Latest papers

Amplification of a calcium channel subunit CACNG4 increases breast cancer metastasis.
EBioMedicine · 2020
TNF and ROS Crosstalk in Inflammation.
Trends in cell biology · 2016 · first author
Targeting Mitosis in Cancer: Emerging Strategies.
Molecular cell · 2015

All 5 publications

Latest funding

Pre-clinical and clinical studies of novel biologics for the treatment of cancer. (2015 S2B CIHR to Rotman Business School)
CIHR · 2015 · Nominated PI
$60,000

All 1 grants and awards

5 publications.

01

Amplification of a calcium channel subunit CACNG4 increases breast cancer metastasis.

Kanwar N, Carmine-Simmen K, Nair R, Wang C, Moghadas-Jafari S, Blaser H, Tran-Thanh D, Wang D, Wang P, Wang J, Pasculescu A, Datti A, Mak T, Lewis JD, Done SJ

EBioMedicine2020

DOI: 10.1016/j.ebiom.2020.102646 PMID: 32062352

02

TNF and ROS Crosstalk in Inflammation.

Blaser H, Dostert C, Mak TW, Brenner D

Trends in cell biology2016First author

DOI: 10.1016/j.tcb.2015.12.002 PMID: 26791157

03

Targeting Mitosis in Cancer: Emerging Strategies.

Dominguez-Brauer C, Thu KL, Mason JM, Blaser H, Bray MR, Mak TW

Molecular cell2015

DOI: 10.1016/j.molcel.2015.11.006 PMID: 26590712

04

Regulation of tumour necrosis factor signalling: live or let die.

Brenner D, Blaser H, Mak TW

Nature reviews. Immunology2015

DOI: 10.1038/nri3834 PMID: 26008591

05

HUNK suppresses metastasis of basal type breast cancers by disrupting the interaction between PP2A and cofilin-1.

Quintela-Fandino M, Arpaia E, Brenner D, Goh T, Yeung FA, Blaser H, Alexandrova R, Lind EF, Tusche MW, Wakeham A, Ohashi PS, Mak TW

Proceedings of the National Academy of Sciences of the United States of America2010

DOI: 10.1073/pnas.0914492107 PMID: 20133759

Pre-clinical and clinical studies of novel biologics for the treatment of cancer. (2015 S2B CIHR to Rotman Business School)

Nominated PICIHR2015Science to Business Program

Principal investigators: Blaser, Heiko M

Keywords: Biologics; Cancer; Monoclonal Antibodies; Oncology; Patient Derived Xenograft; Pre-Clinical; Therapeutics

$60,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Frequent collaborators

Tak Mak

Medical Biophysics & Immunology

1 shared papers, latest 2020

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mention

Subject: Prospective PhD student: Biologics Dear Professor Blaser, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Amplification of a calcium channel subunit CACNG4 increases breast cancer metastasis." (2020), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]